{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:33:41Z","timestamp":1792290821012,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T00:00:00Z","timestamp":1459382400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["52\/22\/2008-BMS"],"award-info":[{"award-number":["52\/22\/2008-BMS"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Glycoconj J"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s10719-016-9658-2","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T07:24:48Z","timestamp":1459409088000},"page":"209-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients"],"prefix":"10.1007","volume":"33","author":[{"given":"Gautam","family":"Mondal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Saroha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha Pratim","family":"Bose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. P.","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,31]]},"reference":[{"key":"9658_CR1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0025-7125(16)30649-6","volume":"73","author":"AM Bisceglie Di","year":"1989","unstructured":"Di Bisceglie A.M.: Hepatocellular carcinoma: molecular biology of its growth and relationship to hepatitis B virus infection. Med. Clin. North Am. 73, 985\u2013997 (1989)","journal-title":"Med. Clin. North Am."},{"key":"9658_CR2","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","volume":"22","author":"TM Block","year":"2003","unstructured":"Block T.M., Mehta A.S., Fimmel C.J., Jordan R.: Molecular viral oncology of hepatocellular carcinoma. Oncogene. 22, 5093\u20135107 (2003)","journal-title":"Oncogene"},{"key":"9658_CR3","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/01.mog.0000218961.86182.8c","volume":"22","author":"JA Marrero","year":"2006","unstructured":"Marrero J.A.: Hepatocellular carcinoma. Curr. Opin. Gastroenterol. 22, 248\u2013253 (2006)","journal-title":"Curr. Opin. Gastroenterol."},{"key":"9658_CR4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0889-8553(21)00154-0","volume":"23","author":"R Sallie","year":"1994","unstructured":"Sallie R., Di Bisceglie A.M.: Viral hepatitis and hepatocellular carcinoma. Gastroenterol. Clin. N. Am. 23, 567\u2013579 (1994)","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"9658_CR5","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","volume":"34","author":"A Lok","year":"2001","unstructured":"Lok A., McMahon B.: Chronic hepatitis B. Hepatology. 34, 1225\u20131241 (2001)","journal-title":"Hepatology"},{"key":"9658_CR6","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1053\/jhep.2001.21041","volume":"33","author":"HB Serag El","year":"2001","unstructured":"El Serag H.B., Mason A.C., Key C.: Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States. Hepatology. 33, 62\u201365 (2001)","journal-title":"Hepatology"},{"key":"9658_CR7","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1023\/B:DDAS.0000030098.75759.32","volume":"49","author":"SA Sarbah","year":"2004","unstructured":"Sarbah S.A., Gramlich T., Younoszai A., Osmack P., Goormastic M., Grosso L., Cooper J.N., Di Bisceglie A., Seneca R., Younossi Z.M.: Risk factors for hepatocellular carcinoma in patients with cirrhosis. Dig. Dis. Sci. 49, 850\u2013853 (2004)","journal-title":"Dig. Dis. Sci."},{"key":"9658_CR8","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1053\/j.gastro.2004.09.014","volume":"127","author":"G Fattovich","year":"2004","unstructured":"Fattovich G., Stroffolini T., Zagni I., Donato F.: Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterol. 127, S35\u2013S50 (2004)","journal-title":"Gastroenterol."},{"key":"9658_CR9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1572-0241.1998.044_c.x","volume":"93","author":"SG Sheth","year":"1998","unstructured":"Sheth S.G., Flamm S.L., Gordon F.D., Chopra S.: AST\/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am. J. Gastroenterol. 93, 44\u201348 (1998)","journal-title":"Am. J. Gastroenterol."},{"key":"9658_CR10","first-page":"734","volume":"95","author":"AL Williams","year":"1988","unstructured":"Williams A.L., Hoofnagle J.H.: Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to Cirrhosis. Gastroenterol. 95, 734\u2013739 (1988)","journal-title":"Relationship to Cirrhosis. Gastroenterol."},{"key":"9658_CR11","first-page":"857","volume":"39","author":"AS Lok","year":"2004","unstructured":"Lok A.S., McMahon B.J.: Practice Guidelines Committee, American association for the study of liver diseases (AASLD). Chronic Hepatitis B: Update of Recommendations. Hepatology. 39, 857\u2013861 (2004)","journal-title":"Chronic Hepatitis B: Update of Recommendations. Hepatology"},{"key":"9658_CR12","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2008\/601583","volume":"25","author":"R Saldova","year":"2008","unstructured":"Saldova R., Wormald M.R., Dwek R.A., Rudd P.M.: Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis. Markers. 25, 219\u2013232 (2008)","journal-title":"Dis. Markers"},{"key":"9658_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/glycob\/cwg041","volume":"13","author":"R Peracaula","year":"2003","unstructured":"Peracaula R., Tabares G., Royle L., Harvey D.J., Dwek R.A., Rudd P.M., de Llorens R.: Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology. 13, 457\u2013470 (2003)","journal-title":"Glycobiology"},{"key":"9658_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1074\/mcp.M900450-MCP200","volume":"9","author":"Y Wada","year":"2010","unstructured":"Wada Y., Dell A., Haslam A.S., et al.: Comparison of methods for profiling O-glycosylation: human proteome organization human disease glycomics\/proteomics multi-institutio9nal study of IgA1. Mol. Cell. Proteomics. 9, 719\u2013727 (2010)","journal-title":"Mol. Cell. Proteomics"},{"key":"9658_CR15","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/glycob\/3.2.97","volume":"3","author":"A Varki","year":"1993","unstructured":"Varki A.: Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3, 97\u2013130 (1993)","journal-title":"Glycobiology"},{"key":"9658_CR16","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/316452a0","volume":"316","author":"RB Parekh","year":"1985","unstructured":"Parekh R.B., Dwek R.A., Sutton B.J., Fernandes D.L., Leung A., Stanworth D., Rademacher T.W., Mizuochi T., Taniguchi T., Matsuta K., Takeuchi F., Nagano Y., Miyamoto T., Kobata A.: Association of rheumatoid arthritis and primary osteoarthritis with changes in the glycosylation pattern of total serum IgG. Nature. 316, 452\u2013457 (1985)","journal-title":"Nature"},{"key":"9658_CR17","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.22171","volume":"54","author":"LA Omtvedt","year":"2006","unstructured":"Omtvedt L.A., Royle L., Husby G., Sletten K., Radcliffe C.M., Harvey D.J., Dwek R.A., Rudd P.M.: Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthr. Rheum. 54, 3433\u20133440 (2006)","journal-title":"Arthr. Rheum"},{"key":"9658_CR18","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1136\/gut.31.4.431","volume":"31","author":"R Dube","year":"1990","unstructured":"Dube R., Rook G.A., Steele J., Brealey R., Dwek R., Rademacher T., Lennard-Jones J.: Agalactosyl IgG in inflammatory bowel disease: correlation with C-reactive protein. Gut. 31, 431\u2013434 (1990)","journal-title":"Gut"},{"key":"9658_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3835(92)90278-4","volume":"66","author":"S Thompson","year":"1992","unstructured":"Thompson S., Dargan E., Turner G.A.: Increased fucosylation and other carbohydrate changes in haptoglobin in ovarian cancer. Cancer Lett. 66, 43\u201348 (1992)","journal-title":"Cancer Lett."},{"key":"9658_CR20","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1093\/glycob\/cwm100","volume":"17","author":"R Saldova","year":"2007","unstructured":"Saldova R., Royle L., Radcliffe C.M., Abd Hamid U.M., Evans R., Arnold J.N., Banks R.E., Hutson R., Harvey D.J., Antrobus R., Petrescu S.M., Dwek R.A., Rudd P.M.: Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology. 17, 1344\u20131356 (2007)","journal-title":"Glycobiology"},{"key":"9658_CR21","doi-asserted-by":"crossref","unstructured":"Otake Y., Fujimoto I., Tanaka F., Nakagawa T., Ikeda T., Menon K.K., Hase S., Wada H., Ikenaka K.: Isolation and characterization of an N-linked oligosaccharide that is significantly increased in sera from patients with non-small cell lung cancer. J. Biochem. (Tokyo). 129(537\u2013452), (2001)","DOI":"10.1093\/oxfordjournals.jbchem.a002888"},{"key":"9658_CR22","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1515\/CCLM.2005.066","volume":"43","author":"B Kossowska","year":"2005","unstructured":"Kossowska B., Ferens-Sieczkowska M., Gancarz R., Passowicz-Muszynska E., Jankowska R.: Fucosylation of serum glycoproteins in lung cancer patients. Clin. Chem. Lab. Med. 43, 361\u2013369 (2005)","journal-title":"Clin. Chem. Lab. Med."},{"key":"9658_CR23","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-4615-1885-3_25","volume":"376","author":"GA Turner","year":"1995","unstructured":"Turner G.A.: Haptoglobin. A potential reporter molecule for glycosylation changes in disease. Adv. Exp. Med. Biol. 376, 231\u2013238 (1995)","journal-title":"Adv. Exp. Med. Biol."},{"key":"9658_CR24","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ijc.21728","volume":"118","author":"N Okuyama","year":"2006","unstructured":"Okuyama N., Ide Y., Nakano M., Nakagawa T., Yamanaka K., Moriwaki K., Murata K., Ohigashi H., Yokoyama S., Eguchi H., Ishikawa O., Ito T., Kato M., Kasahara A., Kawano S., Gu J., Taniguchi N., Miyoshi E.: Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int. J. Cancer. 118, 2803\u20132808 (2006)","journal-title":"Int. J. Cancer"},{"key":"9658_CR25","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/pr050328x","volume":"5","author":"MA Comunale","year":"2006","unstructured":"Comunale M.A., Lowman M., Long R.E., Krakover J., Philip R., Seeholzer S., Evans A.A., Hann H.W., Block T.M., Mehta A.S.: Proteomic analysis of serum associated fucosylated glycoproteins in the development of primary hepatocellular carcinoma. J. Proteome Res. 5, 308\u2013315 (2006)","journal-title":"J. Proteome Res."},{"key":"9658_CR26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0009-8981(91)90024-7","volume":"201","author":"S Thompson","year":"1991","unstructured":"Thompson S., Matta K.L., Turner G.A.: Changes in fucose metabolism associated with heavy drinking and smoking: a preliminary report. Clin. Chim. Acta. 201, 59\u201364 (1991)","journal-title":"Clin. Chim. Acta"},{"key":"9658_CR27","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0009-8981(94)90136-8","volume":"227","author":"AC Mann","year":"1994","unstructured":"Mann A.C., Record C.O., Self C.H., Turner G.A.: Monosaccharide composition of haptoglobin in liver diseases and alcohol abuse: large changes in glycosylation associated with alcoholic liver disease. Clin. Chim. Acta. 227, 69\u201378 (1994)","journal-title":"Clin. Chim. Acta"},{"key":"9658_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(95)06146-0","volume":"243","author":"M Kondo","year":"1995","unstructured":"Kondo M., Hada T., Fukui K., Iwasaki A., Higashino K., Yasukawa K.: Enzyme-linked immunosorbent assay (ELISA) for aleuria aurantia lectin-reactive serum cholinesterase to differentiate liver cirrhosis and chronic hepatitis. Clin. Chim. Acta. 243, 1\u20139 (1995)","journal-title":"Clin. Chim. Acta"},{"key":"9658_CR29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0009-8981(98)00202-2","volume":"281","author":"T Hada","year":"1999","unstructured":"Hada T., Kondo M., Yasukawa K., Amuro Y., Higashino K.: Discrimination of liver cirrhosis from chronic hepatitis by measuring the ratio of Aleuria aurantia lectin-reactive serum cholinesterase to immunoreactive protein. Clin. Chim. Acta. 281, 37\u201346 (1999)","journal-title":"Clin. Chim. Acta"},{"key":"9658_CR30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/1097-0142(19871001)60:7<1630::AID-CNCR2820600735>3.0.CO;2-X","volume":"60","author":"JE Hansen","year":"1987","unstructured":"Hansen J.E., Iversen J., Lihme A., Bog-Hansen T.C.: Acute phase reaction, heterogeneity, and microheterogeneity of serum proteins as nonspecific tumor markers in lung cancer. Cancer. 60, 1630\u20131635 (1987)","journal-title":"Cancer"},{"key":"9658_CR31","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s10719-009-9241-1","volume":"26","author":"G Mondal","year":"2009","unstructured":"Mondal G., Chatterjee U., Das H.R., Chatterjee B.P.: Enhanced expression of \u03b11-acid glycorptein and fucosylation in hepatitis B patients provides an insight into pathogenesis. Glycoconj. J. 26, 1225\u20131234 (2009)","journal-title":"Glycoconj. J."},{"key":"9658_CR32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10719-010-9316-z","volume":"28","author":"G Mondal","year":"2011","unstructured":"Mondal G., Chatterjee U., Chawla Y.K., Chatterjee B.P.: Alterations of glycan branching and differential expression of sialic acid on alpha fetoprotein among hepatitis patients. Glycoconj. J. 28, 1\u20139 (2011)","journal-title":"Glycoconj. J."},{"key":"9658_CR33","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford M.M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248\u2013254 (1976)","journal-title":"Anal. Biochem."},{"key":"9658_CR34","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jchromb.2011.04.024","volume":"879","author":"A Saroha","year":"2011","unstructured":"Saroha A., Biswas S., Chatterjee B.P., Das H.R.: Altered glycosylation and expression of plasma alpha-1-acid glycoprotein and haptoglobin in rheumatoid arthritis. J. Chromatogr. B. 879, 1839\u20131843 (2011)","journal-title":"J. Chromatogr. B"},{"key":"9658_CR35","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1021\/ac950914h","volume":"68","author":"A Shevchenko","year":"1996","unstructured":"Shevchenko A., Wilm M., Vorm O., Mann M.: Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68, 850\u2013858 (1996)","journal-title":"Anal. Chem."},{"key":"9658_CR36","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1559-0275-8-4","volume":"8","author":"LA Rukmangadachar","year":"2011","unstructured":"Rukmangadachar L.A., Kataria J., Hariprasad G., Samantaray J.C., Srinivasan A.: Two dimensional difference gel electrophoresis (DIGE) analysis of sera from visceral leishmaniasis patients. Clin. Proteom. 8, 4 (2011)","journal-title":"Clin. Proteom."},{"key":"9658_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0046374","volume":"7","author":"A Saroha","year":"2012","unstructured":"Saroha A., Kumar S., Chatterjee B.P., Das H.R.: Jacalin bound O-glycoprotein profiling and reduced sialylation of plasma alpha 2-HS glycoprotein (A2HSG) in rheumatoid arthritis patients. PLoS one. 7, e46374 (2012)","journal-title":"PLoS one"},{"key":"9658_CR38","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1039\/C5AN02000J","volume":"141","author":"PP Bose","year":"2016","unstructured":"Bose P.P., Mandal G., Kumar D., Duseja A., Chatterjee B.P.: Visual detection of serum asialohaptoglobin by plasmonic sandwich ELLSA \u2013 a new platform for cirrhosis diagnosis. Analyst. 141, 76\u201384 (2016)","journal-title":"Analyst"},{"key":"9658_CR39","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/elps.200500857","volume":"27","author":"HL Huang","year":"2006","unstructured":"Huang H.L., Stasyk T., Morandell S., Dieplinger H., Falkensammer G., Griesmacher A., Mogg M., Schreiber M., Feuerstein I., Huck C.W., Stecher G., Bonn G.K., Huber L.A.: Biomarker discovery in breast cancer serum using 2D differential gel electrophoresis\/MALDITOF\/TOF and data validation by routine clinical assays. Electrophoresis. 27, 1641\u20131650 (2006)","journal-title":"Electrophoresis"},{"key":"9658_CR40","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","volume":"357","author":"F Imbert-Bismut","year":"2001","unstructured":"Imbert-Bismut F., Ratziu V., Pieroni L., Charlotte F., Benhamou Y.: Poynard, T, MULTIVIRC Group.: biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet. 357, 1069\u20131075 (2001)","journal-title":"Lancet"},{"key":"9658_CR41","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1046\/j.1365-2893.2002.00341.x","volume":"9","author":"T Poynard","year":"2002","unstructured":"Poynard T., Imbert-Bismut F., Ratziu V., Chevret S., Jardel C., Moussalli J., Messous D., Degos F.: GERMED cyt04 group.: Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J. Viral Hepat. 9, 128\u2013133 (2002)","journal-title":"J. Viral Hepat"},{"key":"9658_CR42","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-0676.1988.tb00970.x","volume":"8","author":"R Meliconi","year":"1988","unstructured":"Meliconi R., Parracino O., Facchini A., Morselli-Labate A.M., Bortolotti F., Tremolada F., Martuzzi M., Miglio F., Gasbarrini G.: Acute phase proteins in chronic and malignant liver diseases. Liver. 8, 65\u201374 (1988)","journal-title":"Liver"},{"key":"9658_CR43","first-page":"385","volume":"16","author":"M Borsotti","year":"1980","unstructured":"Borsotti M., De Philippis C., Leoncini F., Mazzotta F., Paci F., Piazza E., Spadolini M.P.: Changes in the serum protein picture in viral hepatitis. II. Evaluation of the Proteins in the Acute Phase. Quad Sclavo Diagn. 16, 385\u2013401 (1980)","journal-title":"II. Evaluation of the Proteins in the Acute Phase. Quad Sclavo Diagn."},{"key":"9658_CR44","first-page":"65","volume":"21","author":"R Pateva","year":"1982","unstructured":"Pateva R., Koichev K., Vurbanov G., Rusinov E., Danev I.: Complex study of glycoproteins in liver disease. Vutreshni Bolesti. 21, 65\u201369 (1982)","journal-title":"Vutreshni Bolesti"},{"key":"9658_CR45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/BF00996837","volume":"36","author":"J Henke","year":"1978","unstructured":"Henke J., Kellner S., Kasulke D.: Haptoglobin- and group-specific component-phenotypes in healthy carriers of antibodies to hepatitis B surface antigen. Blut. 36, 109\u2013110 (1978)","journal-title":"Blut"},{"key":"9658_CR46","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1743-422X-8-274","volume":"8","author":"T Xu-Fei","year":"2011","unstructured":"Xu-Fei T., Shan-Shan W., Shu-Ping L., Zhi C., Feng C.: Alpha-1 antitrypsin is a potential biomarker. Virol. J. 8, 274\u2013280 (2011)","journal-title":"Virol. J."},{"key":"9658_CR47","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1073\/pnas.72.6.2076","volume":"72","author":"SP Daiger","year":"1975","unstructured":"Daiger S.P., Schanfield M.S., Cavalli-Sforza L.L.: Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc. Natl. Acad. Sci. U. S. A. 72, 2076\u20132080 (1975)","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"9658_CR48","first-page":"420","volume":"74","author":"N Yamamoto","year":"1991","unstructured":"Yamamoto N., Homma S., Haddad J.G., Kowalski M.A.: Vitamin D3 binding protein required for in vitro activation of macrophages after alkylglycerol treatment of mouse peritoneal cells. Immunol. 74, 420\u2013424 (1991)","journal-title":"Immunol."},{"key":"9658_CR49","doi-asserted-by":"crossref","unstructured":"Gomme P.T., J.Bertolini .: Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 22, 340\u2013345 (2004)","DOI":"10.1016\/j.tibtech.2004.05.001"},{"key":"9658_CR50","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/liv.12106","volume":"33","author":"CS Stokes","year":"2013","unstructured":"Stokes C.S., Volmer D.A., Grunhage F., Lammert F.: Vitamin D in chronic liver disease. Liver Int. 33, 338\u2013352 (2013)","journal-title":"Liver Int."},{"key":"9658_CR51","unstructured":"Schiodt F.V., Bangert K., Shakil A.O.: McCashland T, Murray N, hay JE. Lee WM: Predictive Value of Actin-Free Gc-Globulin in Acute Liver Failure. Liver Transpl. 13(1324\u20131329), (2007)"},{"key":"9658_CR52","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1210\/jcem-59-1-86","volume":"59","author":"R Bouillon","year":"1984","unstructured":"Bouillon R., Auwerx J., Dekeyser L., Fevery J., Lissens W., De Moor P.: Serum vitamin D metabolites and their binding protein in patients with liver cirrhosis. J. Clin. Endocrinol. Metab. 59, 86\u201389 (1984)","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Glycoconjugate Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-016-9658-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10719-016-9658-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10719-016-9658-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T19:34:52Z","timestamp":1655408092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10719-016-9658-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,31]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9658"],"URL":"https:\/\/doi.org\/10.1007\/s10719-016-9658-2","relation":{},"ISSN":["0282-0080","1573-4986"],"issn-type":[{"value":"0282-0080","type":"print"},{"value":"1573-4986","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,31]]}}}